NCT05747365View on ClinicalTrials.gov

Role of Endocrine Disruptors in Thyroid Cancer

RecruitingOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

July 31, 2025

Conditions
Endocrine Disruptor ChemicalsThyroid Cancer
Interventions
DIAGNOSTIC_TEST

Blood and urine diagnostic evaluation

Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations

Trial Locations (1)

20149

RECRUITING

Istituto Auxologico Italiano, IRCCS, Milan

All Listed Sponsors
lead

Istituto Auxologico Italiano

OTHER